National Institute of Allergy and Infectious Diseases (NIAID): Malaria trials

The registry lists 120 Malaria studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 8 are open to participants now and 19 have results posted.

Phase 1 52Phase 2 12Phase 3 3Phase 4 2No phase 53(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AMA1-C1/Alhydrogel + CpG 7909 for MalariaCompletedNCT00344539Phase 1
• Experimental Vaccine for Malaria in Adults in MaliCompletedNCT00343005Phase 1
• Examination of Protective Factors Against Severe MalariaCompletedNCT00342043
• Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, MaliTerminatedNCT00341783
• Malaria Vaccine in Children in MaliCompletedNCT00341250Phase 1/2
• Severe Malaria and Anti-malarial Drug Resistance in CambodiaCompletedNCT00341003
• Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)CompletedNCT00340574Phase 1
• Experimental Vaccine for Plasmodium Falciparum MalariaCompletedNCT00340431Phase 1
• Malaria Prevalence in ChildrenCompletedNCT00322816
• Time to Infection With Malaria ParasitesCompletedNCT00322738
• Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 AdjuvantCompletedNCT00320658Phase 1
• Fetal Immunity to Falciparum MalariaCompletedNCT00314899
• SP Resistance and Falciparum Malaria TransmissionWithdrawnNCT00299247Phase 3
• Azithromycin Combination Therapy for MalariaCompletedNCT00299208Phase 2
• PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for MalariaCompletedNCT00295581Phase 1
• Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria ResearchCompletedNCT00277849
• Papua New Guinean Duffy Negativity And Vivax MalarTerminatedNCT00138489
• Correlates of Protection in GhanaCompletedNCT00138307
• CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in MalawiCompletedNCT00125489Phase 4
• Experimental Vaccine for MalariaCompletedNCT00114010Phase 1